Showing 1321-1330 of 1861 results for "".
- Galderma Launches Twyneo in the UShttps://practicaldermatology.com/news/galderma-launches-twyneo-in-the-us/2461128/Galderma has launched Twyneo (tretinoin and benzoyl peroxide) Cream, 0.1%/3% in the US. The launch takes place during the annual meeting of the American Academy of Dermatology (AAD) Annual Meeting. Twyneo Cream features patented microencapsulation technology t
- Project IMPACT from VisualDx Marks One Yearhttps://practicaldermatology.com/news/project-impact-from-visualdx-marks-one-year-1/2461123/VisualDx marks the one-year anniversary of
- Dermatology Refresher Symposium for PAs and NPs Coming to San Antoniohttps://practicaldermatology.com/news/dermatology-refresher-symposium-for-pas-and-nps-coming-to-san-antonio/2461112/The 2nd Annual Dermatology Refresher Symposium (DRS) for NPs and PAs comes to Texas next month. The in-person program will be held on April 8-10, 2022 at the Grand Hyatt San Antonio River Walk in San Antonio. DRS is offering com
- Residents of Distinction Recognized at Maui Dermhttps://practicaldermatology.com/news/residents-of-distinction-honored-at-maui-derm/2461111/Sydney Liang, MD, a second-year resident at New York University, was awarded the Overall Grand Prize and was one of five dermatology residents recognized by DermMentors™ as part of the 11th Annual dermMentors™ Resident of Distinction Award™ for 2022.
- First Austrian Skin Cancer Patients Treated with Rhenium-SCT in New Studyhttps://practicaldermatology.com/news/first-austrian-skin-cancer-patients-treated-with-rhenium-sct-in-new-study/2461110/The first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT– for the treatment of non-melanoma skin cancer), according to OncoBeta GmbH. "This is an important step for better u
- Novan, Inc. Acquires EPI Healthhttps://practicaldermatology.com/news/novan-inc-acquires-epi-health/2461106/EPI Health is now a Novan Company. The EP Group today announced the acquisition of EPI Health, LLC by Novan, Inc. EPI Health is a leading company in the US dermatology sector with an established sales force and commercial team with existing, deep market relationships across the de
- Aquaphor Unveils New Purpose-Driven Brand Campaignhttps://practicaldermatology.com/news/aquaphor-unveils-new-purpose-driven-brand-campaign/2461099/Aquaphor is launching its first-ever brand purpose campaign, "Before & Aquaphor." Inspired by the growing field of psychodermatology, this new integrated campaign highlights the connection between our skin health and our emotional well-being.
- Study Establishes Optimal Drug Delivery Settings for Needle-free Jet Injectorshttps://practicaldermatology.com/news/study-establishes-optimal-drug-delivery-settings-for-needle-free-jet-injectors/2461085/Needle-free jet injectors have been used in dermatological practice for many years for the nearly pain-free transdermal drug delivery for indications such as hypertrophic scars, keloids, and warts, but predefined clinical endpoints that guide physicians to choose optimal device settings have not
- Solta Medical Files for IPOhttps://practicaldermatology.com/news/solta-medical-files-for-ipo/2461072/Bausch Subsidiary Solta Medical Corporation is getting ready to go public. The Company publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering ("IPO") of Solta's common shares.
- National Foundation for Cancer Research Taps NYC Dermatologist for Board Seathttps://practicaldermatology.com/news/national-foundation-for-cancer-research-taps-dermatologist-for-board-seat/2461065/The National Foundation for Cancer Research (NFCR) has announced that New York dermatologist Dr. Karen Burke and two others will be joining the board. NFCR was founded in 1973 to support cancer research and public education relating to the prevention, early diagnosis, better treatments